0001655566-21-000002.txt : 20211123
0001655566-21-000002.hdr.sgml : 20211123
20211123092558
ACCESSION NUMBER: 0001655566-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211123
DATE AS OF CHANGE: 20211123
EFFECTIVENESS DATE: 20211123
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sermonix Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001655566
IRS NUMBER: 472551294
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-422178
FILM NUMBER: 211435153
BUSINESS ADDRESS:
STREET 1: 3000 E. MAIN ST
CITY: COLUMBUS
STATE: OH
ZIP: 43209
BUSINESS PHONE: (614) 864-4919
MAIL ADDRESS:
STREET 1: 3000 E. MAIN ST
CITY: COLUMBUS
STATE: OH
ZIP: 43209
FORMER COMPANY:
FORMER CONFORMED NAME: Sermonix Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20151014
D
1
primary_doc.xml
X0708
D
LIVE
0001655566
Sermonix Pharmaceuticals, Inc.
3000 E. MAIN ST
COLUMBUS
OH
OHIO
43209
(614) 864-4919
DELAWARE
Sermonix Pharmaceuticals, LLC
Corporation
true
Thomas
Pfisterer
3000 E. Main St
Columbus
OH
OHIO
43209
Director
Anthony
Wild
3000 E. Main St
Columbus
OH
OHIO
43209
Executive Officer
Director
David
Portman
3000 E. Main St
Columbus
OH
OHIO
43209
Executive Officer
Director
Promoter
Richard
De Schutter
3000 E. Main St
Columbus
OH
OHIO
43209
Director
Michael
Friedman
3000 E. Main St
Columbus
OH
OHIO
43209
Director
Elizabeth
Garner
3000 E. Main St
Columbus
OH
OHIO
43209
Director
Miriam
Portman
3000 E. Main St
Columbus
OH
OHIO
43209
Executive Officer
Promoter
Elizabeth
Attias
3000 E. Main St
Columbus
OH
OHIO
43209
Executive Officer
Paul
Plourde
3000 E. Main St
Columbus
OH
OHIO
43209
Executive Officer
Barry
Komm
3000 E. Main St
Columbus
OH
OHIO
43209
Executive Officer
Simon
Jenkins
3000 E. Main St
Columbus
OH
OHIO
43209
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2021-11-12
false
true
false
0
LIFESCI CAPITAL
168404
None
None
250 W. 55 St
Suite 3401
New York
NY
NEW YORK
10019
NY
NEW YORK
false
40225000
40225000
0
false
9
2220000
0
0
The Company will use the proceeds for general working capital purposes, including but not limited to employee salaries.
false
Sermonix Pharmaceuticals, Inc.
David Portman
David Portman
President
2021-11-22